​#SocialCurrentSee®▶ #'Waksaled' *

* # 'WAKSAL'ed = This coined moniker pertains to the story of medical entrepreneur Sam Waksal and his link to notable author and lifestyle guru Martha Stewart. One could easily file this story under the generic title, "The more things change, the more they remain the same."

Black-listed on more than just Wikipedia, Samuel D. "Sam" Waksal, Ph.D., (born September 8, 1947) is the founder and former CEO of the biopharmaceutical company ImClone Systems. He is also the founder and CEO of Kadmon Pharmaceuticals which was financed with private capital and commenced operations in New York City in 2010. At ImClone, Waksal led the company to develop the landmark cancer drug Erbitux (cetuximab). During the course of its review process with Food and Drug Administration (FDA) Waksal became involved in an FBI insider trading scandal revolving around improper communications with personal friends and family members. He was convicted of several securities violations, served time in federal prison, and was released.

As seen on SocialCurrentSee
Today's Tweets are Tomorrow's Posts and some of our posts here come from a KINDLE read.

▶ Social networking by @ALTALOMAN, mobile web concierge, archivist, synergist, micro blogger "INtrepreneur"... retired from hospital fund development and a cancer survivor

▶ Besides the Twitter roll below, followers will find additional content in our #SocialCurrentSee on Flipboard and on @Storify : http://browseonpurpose.com

▶ CASTING the constant comments, stories, and 'social current see' (SCS) of publisher, curator, webmaster ALTALOMAN with a view of the sites below.   

▶ Now retired but fully enjoying status as GPx2*, Mike & Dee Dee celebrate his survival with mantle cell lymphoma (MCL) since Mar. 06, including a stem cell transplant from an unrelated donor in 2007 and "TomoTherapy" in 2009.   * GPx2 = grandparents times two

▶ My story in the sites and blogs of my SCS at the links in this profile.

▶ Content archived on Blogger, Facebook, Flipboard, G+, Linkedin, Storify, Twitter, and YouTube with more than 15,000 readers and followers